泰德医药（浙江）股份有限公司（股票代码：03880）于2026年5月6日发布2026年4月股份变动月报表，披露公司截至2026年4月30日的股本情况。
根据公告，公司普通股H股于香港联交所上市，期末已发行H股数量为141,800,000股，每股面值人民币1元，对应已发行股本人民币1.42亿元，与上月末持平。公告显示，报告期内公司未发生新增发行、回购、注销或库藏股变动，现有股本规模保持不变。
公告中还显示，本月公司并无新的股份期权或股权激励计划变动，也不存在任何可转换证券、权证或其他协议安排所导致的权益变动。截至报告期末，公司确认满足在香港联交所上市的最低公众持股量要求。
此外，公司表示已遵守香港联交所《上市规则》及相关法律规定。公告由联席公司秘书吴东澄签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.